NCT03243175View on ClinicalTrials.gov

Avoiding Anticoagulation After IntraCerebral Haemorrhage

PHASE3RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 17, 2019

Primary Completion Date

January 31, 2026

Study Completion Date

December 31, 2028

Conditions
Intracerebral HemorrhageAtrial FibrillationMicrohaemorrhage
Interventions
DRUG

Apixaban 5 MG

Apixaban 5mg x 2 during 24 months

DEVICE

left atrial appendage closure

left atrial appendage closure

Trial Locations (3)

Unknown

RECRUITING

Hôpital Roger Salengro, CHU, Lille

RECRUITING

GHICL, Lomme

RECRUITING

CH De Tourcoing, Tourcoing

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

University Hospital, Lille

OTHER